Trial Review

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12605000342617
Ethics application status
Approved
Date submitted
6/09/2005
Date registered
9/09/2005
Date last updated
9/09/2005
Type of registration
Retrospectively registered

Titles & IDs
Public title
Comparison of two different doses of paracetamol for post-operative pain relief
Scientific title
Comparison of two different doses of paracetamol for post-operative pain relief
Secondary ID [1] 144 0
Comparison of two different doses of paracetamol for post-operative pain relief
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Fit ASA 1-2 adult patients 435 0
Condition category
Condition code
Alternative and Complementary Medicine 507 507 0 0
Spiritual care

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Cross over trail with 60 mg/kg or 90 mg/kg of paracetamol.
Intervention code [1] 370 0
Treatment: Drugs
Comparator / control treatment
Control group
Dose comparison

Outcomes
Primary outcome [1] 578 0
Pain relief
Timepoint [1] 578 0
Secondary outcome [1] 1233 0
Blood levels (pharmacokinetics)
Timepoint [1] 1233 0
Secondary outcome [2] 1234 0
Metabolism of paracetamol
Timepoint [2] 1234 0

Eligibility
Key inclusion criteria
(ASA 1-2) with bilaterally impacted 3rd molar teeth are included.
Minimum age
18 Years
Maximum age
Not stated
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Pregnant patients, patients with liver disease, children.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Drugs were available in sealed brown paper bags (with patient's number, name and weight written on it), which were opened immediately prior to operation on the first side. Each bag contained 2 bottles labelled with the name of patient, weight of the patients and operation sequence (first operation side or second operation side). Each bottle contained same number of indistinguishable capsules. Randomisation, allocation concealment and blinding were done by the pharmacy which made up the sealed brown paper bags with name of patient written on its outside, to be collected by one of the researchers the day before the trial on a patient. Investigators and patients were blinded to the treatment allocation.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Randomised in blocks using random number generator in Excel.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



Intervention assignment
Crossover
Other design features
Placebo capsules along with active capsules (indistingushable)
Phase
Phase 4
Type of endpoint/s
Pharmacokinetics / pharmacodynamics
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
5/01/2005
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
18
Accrual to date
Final
Recruitment outside Australia
Country [1] 170 0
New Zealand
State/province [1] 170 0

Funding & Sponsors
Funding source category [1] 569 0
Other Collaborative groups
Name [1] 569 0
Australina & New Zealand College of Anaesthetists
Country [1] 569 0
Primary sponsor type
Other Collaborative groups
Name
ANZCA
Address
Country
Secondary sponsor category [1] 461 0
Hospital
Name [1] 461 0
Dept of Anaesthesia, Dunedin Hospital
Address [1] 461 0
Dunedin
Country [1] 461 0
New Zealand

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 1592 0
Otago Ethics Committee (Lower South Island Ethics Committee)
Ethics committee address [1] 1592 0
Ethics committee country [1] 1592 0
New Zealand
Date submitted for ethics approval [1] 1592 0
Approval date [1] 1592 0
Ethics approval number [1] 1592 0

Summary
Brief summary
Paracetamol is commonly used to reduce pain after operations. Recently anaesthetists have been using bigger doses of paracetamol because it has been suggested that bigger doses will work better. However these bigger doses have never been assessed scientifically in adult patients to see if they work better, and it has not been determined at which dose the maximum effect in reducing pain occurs. We will investigate whether a 90 mg per kg body weight dose works better than a 60 mg per kilogram dose, in reducing pain after wisdom tooth extraction. We will also examine the pharmacokinetics (the way the body removes the drug) of paracetamol, and whether paracetamol changes the way blood clots at these doses. We will also examine whether these doses are safe, by monitoring liver enzymes, and making sure the blood level of paracetamol is not greater than that previously recognised to cause liver disease. The patients will be healthy volunteers scheduled to have wisdom tooth extraction. They will have blood taken at intervals for four hours after having the paracetamol. They will fill in pain scores at the same times they have blood taken.
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 36377 0
Address 36377 0
Country 36377 0
Phone 36377 0
Fax 36377 0
Email 36377 0
Contact person for public queries
Name 9559 0
Dr Mathew Zacharias
Address 9559 0
Department of Anaesthesia and Intensive Care
Dunedin Hosptial
Dunedin Otago 913
Country 9559 0
New Zealand
Phone 9559 0
+64 3 4740999
Fax 9559 0
+64 3 4747650
Email 9559 0
[email protected]
Contact person for scientific queries
Name 487 0
Dr Mathew Zacharias
Address 487 0
Department of Anaesthesia and Intensive Care
Dunedin Hosptial
Dunedin Otago 913
Country 487 0
New Zealand
Phone 487 0
+64 3 4740999
Fax 487 0
+64 3 4747650
Email 487 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.